Provectus Biopharmaceuticals, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2011
Total Assets: $13.3M
Liabilities Breakdown FY2011
Total Liabilities: $3.3M
Asset Breakdown
Total Assets: $13.3M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $7.7M | 57.7% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $20.1K | 0.2% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $5.6M | 41.9% |
| Other Assets | $27.0K | 0.2% |
Liabilities Breakdown
Total Liabilities: $3.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $101.1K | 3.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $3.2M | 97.0% |